Abstract
The need to better predict the development of insulin resistance (IR) and type 2 diabetes (T2D) is necessary as the prevalence of T2D is projected to increase in Canada and cost Canadians ∼$18 billion by 2030. The International Diabetes Federation currently advises the use of total blood triglycerides (TGs) as a predictor for identifying individuals at risk of developing IR and T2D. However, it has been demonstrated that total TG levels do not reliably reflect IR across multiple ethnicities. This suggests that a more accurate marker of IR is required. Interestingly, recent evidence suggests that distinct fatty acids (FAs) in blood TGs can reflect an individual’s IR status more accurately than total TGs. It is therefore reasonable to postulate that an analysis of the FAs within TGs and other blood lipids could lead to the discovery of a more accurate marker of IR. Over the course of 3 studies, the following thesis aimed to demonstrate that distinct FAs within serum lipids are associated with markers of IR more robustly than total TGs or total FAs. First, a large cross-sectional cohort that comprised young adults was used to demonstrate the associations between individual serum FAs and markers of IR (e.g., fasting glucose). Second, a population of Caucasian men that varied in IR-risk was examined to demonstrate that specific serum FAs within TGs associate with markers of IR more strongly than total TG levels. Finally, a cohort of individuals was investigated to demonstrate the improved ability of phospholipid and TG FA profiles (compared with total FAs) to distinguish individuals varying in metabolic health. This thesis demonstrated that circulating FAs associate with markers of IR and that these associations vary between individuals of different sex and ethnicity. Furthermore, the findings of this thesis indicate that compared with total serum TGs, specific FAs within lipid fractions may provide a more accurate means to identify individuals at increased risk of developing IR and T2D. Collectively, this thesis encourages future investigations of FAs within serum lipid fractions to uncover an improved method for identifying individuals at risk of IR and T2D.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.